Ibuprofen rescues abnormalities in periodontal tissues in conditional presenilin 1 and presenilin 2 double knockout mice

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18457-18469

  Su, Jianshing ^a   Gu, Jiamei ^a   Dong, Zhuo ^b   Mei, Bing ^b  

^a TONGJI UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Ibuprofen; Inflammatory response; Periodontal tissues; Presenilins

Indexed keywords

CALCITONIN RECEPTOR; IBUPROFEN; PRESENILIN 1; PRESENILIN 2; PROSTAGLANDIN SYNTHASE;

ALVEOLAR BONE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GINGIVA; HIPPOCAMPUS; HISTOPATHOLOGY; INCISOR; INFLAMMATION; KNOCKOUT MOUSE; MANDIBLE; MAXILLA; MOUSE; NONHUMAN; OSTEOCLAST; PERIODONTAL DISEASE; PRESENILIN 1 GENE; PRESENILIN 2 GENE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IBUPROFEN; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; PERIODONTAL DISEASES; PERIODONTIUM; PRESENILIN-1; PRESENILIN-2;

EID: 84883695970     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918457     Document Type: Article

References (39)

1. Hutton, M.; Hardy, J. The presenilins and Alzheimer's disease. Hum. Mol. Genet. 1997, 6, 1639-1646.
2. Feng, R.; Rampon, C.; Tang, Y.P.; Shrom, D.; Jin, J.; Kyin, M.; Sopher, B.; Miller, M.W.; Ware, C.B.; Martin, G.M.; et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 2001, 32, 911-926.
3. Donoviel, D.B.; Hadjantonakis, A.K.; Ikeda, M.; Zheng, H.; Hyslop, P.S.; Bernstein, A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 1999, 13, 2801-2810.
4. Shen, J.; Kelleher, R.J. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. USA 2007, 104, 403-409.
5. Saura, C.A.; Choi, S.Y.; Beglopoulos, V.; Malkani, S.; Zhang, D.; Shankaranarayana Rao, B.S.; Chattarji, S.; Kelleher, R.J., Kandel, E.R.; Duff, K. et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42, 23-36.
6. Feng, R.; Wang, H.; Wang, J.; Shrom, D.; Zeng, X.; Tsien, J.Z. Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc. Natl. Acad. Sci. USA 2004, 101, 8162-8167.
7. Jiang, X.; Zhang, D.; Shi, J.; Chen, Y.; Zhang, P.; Mei, B. Increased inflammatory response both in brain and in periphery in presenilin 1 and presenilin 2 conditional double knock-out mice. J. Alzheimer's Dis. 2009, 18, 515-523.
8. Beglopoulos, V.; Sun, X.; Saura, C.A.; Lemere, C.A.; Kim, R.D.; Shen, J. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol.Chem. 2004, 279, 46907-46914.
9. Wang, D.; Yang, L.; Su, J.; Niu, Y.; Lei, X.; Xiong, J.; Cao, X.; Hu, Y.; Mei, B.; Hu, J.F. Attenuation of neurodegenerative phenotypes in Alzheimer-like presenilin 1/presenilin 2 conditional double knockout mice by EUK1001, a promising derivative of xanomeline. Biochem. Biophys. Res. Comm. 2011, 410, 229-234.
10. Armitage, G.C. Periodontal diagnoses and classification of periodontal diseases. Periodontology 2000 2004, 34, 9-21.
11. Ebersole, J.L.; Cappelli, D.; Mathys, E.C.; Steffen, M.J.; Singer, R.E.; Montgomery, M.; Mott, G.E.; Novak, M.J. Periodontitis in humans and non-human primates: Oral-systemic linkage inducing acute phase proteins. Ann. Periodontol. 2002, 7, 102-111.
12. Kamer, A.R.; Morse, D.E.; Holm-Pedersen, P.; Mortensen, E.L.; Avlund, K. Periodontal inflammation in relation to cognitive function in an older adult Danish population. J. Alzheimer's Dis. 2012, 28, 613-624.
13. Stewart, R.; Sabbah, W.; Tsakos, G.; D'Aiuto, F.; Watt, R.G. Oral health and cognitive function in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom. Med. 2008, 70, 936-941.
14. Grabe, H.J.; Schwahn, C.; Volzke, H.; Spitzer, C.; Freyberger, H.J.; John, U.; Mundt, T.; Biffar, R.; Kocher, T. Tooth loss and cognitive impairment. J. Clin. Periodontol. 2009, 36, 550-557.
15. Kaye, E.K.; Valencia, A.; Baba, N.; Spiro, A.; Dietrich, T.; Garcia, R.I. Tooth loss and periodontal disease predict poor cognitive function in older men. J. Am. Geriatr. Soc. 2010, 58, 713-718.
16. Ellefsen, B.; Holm-Pedersen, P.; Morse, D.E.; Schroll, M.; Andersen, B.B.; Waldemar, G. Assessing caries increments in elderly patients with and without dementia: A one-year follow-up study. J. Am. Dent. Assoc. 2009, 140, 1392-1400.
17. Avlund, K.; Holm-Pedersen, P.; Morse, D.E.; Viitanen, M.; Winblad, B. Tooth loss and caries prevalence in very old Swedish people: The relationship to cognitive function and functional ability. Gerodontology 2004, 21, 17-26.
18. Ellefsen, B.; Holm-Pedersen, P.; Morse, D.E.; Schroll, M.; Andersen, B.B.; Waldemar, G. Caries prevalence in older persons with and without dementia. J. Am. Geriatr. Soc. 2008, 56, 59-67.
19. Han, W.; Ji, T.; Wang, L.; Yan, L.; Wang, H.; Luo, Z.; Mei, B.; Su, J. Abnormalities in periodontal and salivary tissues in conditional presenilin 1 and presenilin 2 double knockout mice. Mol. Cell. Biochem. 2011, 347, 13-20.
20. McGeer, P.L.; Schulzer, M.; McGeer, E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 1996, 47, 425-432.
21. Stewart, W.F.; Kawas, C.; Corrada, M.; Metter, E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48, 626-632.
22. Vlad, S.C.; Miller, D.R.; Kowall, N.W.; Felson, D.T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008, 70, 1672-1677.
23. Howell, T.H.; Williams, R.C. Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Crit. Rev. Oral Biol. Med. 1993, 4, 177-196.
24. Lim, G.P.; Yang, F.; Chu, T.; Chen, P.; Beech, W.; Teter, B.; Tran, T.; Ubeda, O.; Ashe, K.H.; Frautschy, S.A.; et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 2000, 20, 5709-5714.
25. Lim, G.P.; Yang, F.; Chu, T.; Gahtan, E.; Ubeda, O.; Beech, W.; Overmier, J.B.; Hsiao-Ashec, K.; Frautschy, S.A.; Cole, G.M. Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol. Aging 2001, 22, 983-991.
26. Cochran, D.L. Inflammation and bone loss in periodontal disease. J. Periodontol. 2008, 79, 1569-1576.
27. Yamamoto, T.; Domon, T.; Takahashi, S.; Islam, N.; Suzuki, R.; Wakita, M. The structure and function of periodontal ligament cells in acellular cementum in rat molars. Ann. Anat. 1998, 180, 519-522.
28. Noble, J.M.; Scarmeas, N. (Cognitive Impairment) Improving Oral Health for the Elderly, 1st ed.; Springer Science & Business Media: New York, NY, USA, 2008; pp. 99-126.
29. Mei, B. East China Normal University, Shanghai, China. Unpublished observation, 2013.
30. Stalder, A.K.; Carson, M.J.; Pagenstecher, A.; Asensio, V.C.; Kincaid, C.; Benedict, M.; Powell, H.C.; Masliah, E.; Campbell, I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 1998, 153, 767-783.
31. Yang, Y.; Quitschke, W.W.; Brewer, G.J. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. Brain Res. 1998, 60, 40-49.
32. Li, Y.; Liu, L.; Barger, S.W.; Griffin, W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 2003, 23, 1605-1611.
33. In't Veld, B.A.; Ruitenberg, A.; Hofman, A.; Launer, L.J.; van Duijn, C.M.; Stijnen, T.; Breteler, M.M.; Stricker, B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Eng. J. Med. 2001, 345, 1515-1521.
34. Simmons, D.L.; Botting, R.M.; Hla, T. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56, 387-437.
35. McGeer, P.L. Cyclo-oxygenase-2 inhibitors: Rationale and therapeutic potential for Alzheimer's disease. Drugs Aging 2000, 17, 1-11.
36. Heneka, M.T.; Sastre, M.; Dumitrescu-Ozimek, L.; Hanke, A.; Dewachter, I.; Kuiperi, C.; O'Banion, K.; Klockgether, T.; van Leuven, F.; Landreth, G.E. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 2005, 128, 1442-1453.
37. Hoozemans, J.J.; Veerhuis, R.; Rozemuller, A.J.; Eikelenboom, P. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease. Curr. Drug Targets 2003, 4, 461-468.
38. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L. et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21, 383-421.
39. Dong, S.; Li, C.; Wu, P.; Tsien, J.Z.; Hu, Y. Environment enrichment rescues the neurodegenerative phenotypes in presenilins-deficient mice. Eur. J. Neurosci. 2007, 26, 101-112.